Biotechnology

Protein engineering is a field primed for artificial intelligence research. Each protein is made up of amino acids; to optimize a protein function, researchers modify proteins by switching out one of 20 different amino...

From single-molecule fluorescence to nanopore readouts, emerging platforms are opening a new window into the hidden diversity of proteins that mass spectrometry can miss. Review: The Next Generation of Protein Sequencing and Analysis Methods. Image...

Nanyang Technological University, Singapore (NTU Singapore) is working with China's Southern University of Science and Technology (SUSTech) and Swedish biotechnology company Lipigon Pharmaceuticals AB to develop a new inhaled treatment aimed at helping patients...

Alligator Bioscience, a clinical-stage biotechnology company developing tumor-directed immuno-oncology antibody drugs, today provided a brief update regarding mitazalimab. In parallel with ongoing partnering activities, Alligator is exploring alternative opportunities for phase 3 development of mitazalimab...

As the AI era becomes increasingly shaped by foundation models, the pharmaceutical industry is entering a new phase of opportunity for discovery, design, and decision-making driven by AI for science. To explore these advancements,...

As the AI era becomes increasingly shaped by foundation models, the pharmaceutical industry is entering a new phase of opportunity for discovery, design, and decision-making driven by AI for science. To explore these advancements,...

FairJourney Bio (FJBio), a CRO, opened its advanced cryo-electron microscopy (cryo-EM) structural biology facility in San Diego. The new site significantly expands the company’s presence in the U.S. market and incorporates atomic-resolution structural biology...

Intracellular transport is a vital process that allows cells to move proteins and other molecules to specific locations. This process is especially important in neurons, which have highly polarized structures with long extensions such...

For more than a decade, BET inhibitors have been touted as one of cancer therapy’s most promising drug classes. The logic was straightforward: many tumors rely on oncogenes that depend on BET (bromo- and...

This week, Seer, a developer of proteomics technology, said that scientists involved in the PRECISE-SG100K initiative will use the company’s Proteograph® product suite to profile the plasma proteome of about 10,000 participants. The data...